Search - tctmd.com

Displaying 861 - 880 of 10338

Sort: Relevancy | Date

Presentation TCT 2016

No Metallic Implants Anymore: The Case for Routine DCB!

Presenter: Tony Das, Koen Deloose, Subhash Banerjee

October 31, 2016

Presentation TCT 2016

How to Establish and Grow a CTO Program: Essentials and Pitfalls

Presenter: James C. Spratt, Simon J. Walsh, Farouc Jaffer

October 31, 2016

Presentation TCT 2016

Flash Debate: Counterpoint 4D-CT Leaflet Imaging Findings Will Help to Direct Anticoagulation Therapy!

Presenter: Raj Makkar, Lars Sondergaard

October 31, 2016

Presentation TCT 2016

Building the CHIP Heart Team: Institutional and Network Strategies for a Successful CHIP Program

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Jonathan M. Hill

October 31, 2016

Presentation TCT 2016

Pre-EXCEL and NOBLE: What Have We Learned From Contemporary Left Main Randomized Trials?

Presenter: Seung-Jung Park, Leif Thuesen, Marie-Claude Morice

October 31, 2016

Presentation TCT 2016

MATRIX Critique: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, Frederick Feit

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty IV: Millipede

Presenter: Ted Feldman, Scott Lim, Jason H. Rogers

October 31, 2016

Presentation TCT 2016

Post-PCI FFR Measurements: Lessons From FAME I and II

Presenter: Allen Jeremias, Nico H.J. Pijls, Zsolt Piroth

October 31, 2016

Presentation TCT 2016

Flash Debate: Point 4D-CT Leaflet Thickening Is an Imaging Curiosity With No Clinical Relevance!

Presenter: Raj Makkar, Lars Sondergaard, Ganesh Manoharan

October 31, 2016

Presentation TCT 2016

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: Vulnerable Plaque Is the Single Most Important Factor!

Presenter: Ran Kornowski, Michel R. Le May, Tej Sheth

October 31, 2016

Presentation TCT 2016

Early Insights From the DELTA-2 Registry

Presenter: Seung-Jung Park, Leif Thuesen, Alaide Chieffo

October 31, 2016

Presentation TCT 2016

Clinical Risk Assessment and Health Status Goals in the CHIP Population

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Adam C. Salisbury

October 31, 2016

Presentation TCT 2016

Acute Cardiogenic Shock Treatment Algorithm 3: The Case for First-line Use of ECMO

Presenter: Simon R. Dixon, Holger Thiele, A. Reshad Garan

October 31, 2016

Presentation TCT 2016

The Alphabet Soup of SFA Scaffolds and Their Outcomes: BMS, VMI, DES, PTFE

Presenter: Tony Das, Koen Deloose, Ehrin J. Armstrong

October 31, 2016

Presentation TCT 2016

Intervention for Venous Disease

Presenter: Raghu Kolluri, Vishal Kapur

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty III: Guided Delivery Systems Results, Device Iterations, and Future Directions

Presenter: Ted Feldman, Scott Lim, Horst Sievert

October 31, 2016

Presentation TCT 2016

Failure Modes of Bioresorbable Scaffolds: From the Obvious (Strut Thickness Considerations) to the Novel (Intraluminal Scaffold Dismantling)

Presenter: Elazer R. Edelman, Juan F. Granada

October 31, 2016

Presentation TCT 2016

What Have We Learned From Contemporary Left Main Observational Studies IV? FLORENCE-LM Registry

Presenter: Seung-Jung Park, Leif Thuesen, David Antoniucci (RETIRED)

October 31, 2016

Presentation TCT 2016

Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS

Presenter: Sunil V. Rao, Harvey D. White, Salvatore Brugaletta

October 31, 2016

Presentation TCT 2016

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: The Degree of Stenosis/Ischemia Is Most Important!

Presenter: Ran Kornowski, Michel R. Le May, Anthony H. Gershlick

October 31, 2016

Advertisement

No Metallic Implants Anymore: The Case for Routine DCB!

How to Establish and Grow a CTO Program: Essentials and Pitfalls

Flash Debate: Counterpoint 4D-CT Leaflet Imaging Findings Will Help to Direct Anticoagulation Therapy!

Building the CHIP Heart Team: Institutional and Network Strategies for a Successful CHIP Program

Pre-EXCEL and NOBLE: What Have We Learned From Contemporary Left Main Randomized Trials?

MATRIX Critique: Pros and Cons

Direct Annuloplasty IV: Millipede

Post-PCI FFR Measurements: Lessons From FAME I and II

Flash Debate: Point 4D-CT Leaflet Thickening Is an Imaging Curiosity With No Clinical Relevance!

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: Vulnerable Plaque Is the Single Most Important Factor!

Early Insights From the DELTA-2 Registry

Clinical Risk Assessment and Health Status Goals in the CHIP Population

Acute Cardiogenic Shock Treatment Algorithm 3: The Case for First-line Use of ECMO

The Alphabet Soup of SFA Scaffolds and Their Outcomes: BMS, VMI, DES, PTFE

Intervention for Venous Disease

Direct Annuloplasty III: Guided Delivery Systems Results, Device Iterations, and Future Directions

Failure Modes of Bioresorbable Scaffolds: From the Obvious (Strut Thickness Considerations) to the Novel (Intraluminal Scaffold Dismantling)

What Have We Learned From Contemporary Left Main Observational Studies IV? FLORENCE-LM Registry

Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: The Degree of Stenosis/Ischemia Is Most Important!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content